157 related articles for article (PubMed ID: 7106368)
1. The dissociation rate of estrogen receptor-ligand complexes is increased by high concentrations of steroids and antiestrogens.
Borgna JL; Ladrech S
Mol Cell Endocrinol; 1982 Jun; 27(1):1-15. PubMed ID: 7106368
[TBL] [Abstract][Full Text] [Related]
2. The effect of free DNA on the interactions of the estrogen receptor bound to hormone, partial antagonist or pure antagonist with target DNA.
Aliau S; Groblewski T; Borgna JL
Eur J Biochem; 1995 Jul; 231(1):204-13. PubMed ID: 7628472
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
Borgna JL; Scali J
J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
[TBL] [Abstract][Full Text] [Related]
4. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
Borgna JL; Scali J
Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
Keene JL; Ruh MF; Ruh TS
J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530
[TBL] [Abstract][Full Text] [Related]
6. Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor.
Tate AC; Greene GL; DeSombre ER; Jensen EV; Jordan VC
Cancer Res; 1984 Mar; 44(3):1012-8. PubMed ID: 6692388
[TBL] [Abstract][Full Text] [Related]
7. Conversion of estrogen receptor from a state with low affinity for estradiol into a state of higher affinity does not require 4S to 5S dimerization.
Müller RE; Traish AM; Hirota T; Bercel E; Wotiz HH
Endocrinology; 1985 Jan; 116(1):337-45. PubMed ID: 2981069
[TBL] [Abstract][Full Text] [Related]
8. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
Ruh TS; Baudendistel LJ
Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
[TBL] [Abstract][Full Text] [Related]
9. Diethylstilbestrol metabolites and analogs: differential ligand effects on estrogen receptor interactions with nuclear matrix sites.
Metzger DA; Curtis S; Korach KS
Endocrinology; 1991 Apr; 128(4):1785-91. PubMed ID: 2004602
[TBL] [Abstract][Full Text] [Related]
10. Ligand-receptor dissociation: a potential mechanism for the attenuation of estrogen action in the juvenile rabbit uterus.
Chilton BS; Williams ND; Cobb AD; Leavitt WW
Endocrinology; 1987 Feb; 120(2):750-7. PubMed ID: 3803303
[TBL] [Abstract][Full Text] [Related]
11. Estriol and estradiol interactions with the estrogen receptor in vivo and in vitro.
Müller RE; Beebe DM; Bercel E; Traish AM; Wotiz HH
J Steroid Biochem; 1984 Apr; 20(4B):1039-46. PubMed ID: 6727349
[TBL] [Abstract][Full Text] [Related]
12. Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin.
Bouhoute A; Leclercq G
Biochem Biophys Res Commun; 1992 May; 184(3):1432-40. PubMed ID: 1590802
[TBL] [Abstract][Full Text] [Related]
13. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
[TBL] [Abstract][Full Text] [Related]
14. Chronic estrogen treatment causes an alteration in uterine estrogen receptor dynamics of rats.
Sato B; Nishizawa Y; Noma K; Kishimoto S; Matsumoto K
Biochim Biophys Acta; 1983 Feb; 755(3):412-9. PubMed ID: 6824737
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-receptor--DNA interaction. Difference between activation by estrogen and antiestrogen.
Evans E; Baskevitch PP; Rochefort H
Eur J Biochem; 1982 Nov; 128(1):185-91. PubMed ID: 7173202
[TBL] [Abstract][Full Text] [Related]
16. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
[TBL] [Abstract][Full Text] [Related]
17. Antiestrogen pharmacology and mechanism of action.
Katzenellenbogen BS; Miller MA; Eckert RL; Sudo K
J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor in chicken oviduct: receptor dissociation kinetics and transformation.
de Boer W; Ab G; Gruber M
J Steroid Biochem; 1985 Jul; 23(1):9-18. PubMed ID: 4021495
[TBL] [Abstract][Full Text] [Related]
19. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
Attardi B; Happe HK
Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
